Abstract: Methods, systems, and devices for memory operations are described. A first code for detecting one or more errors in a first set of bits of data and a second code for detecting one or more errors in a second set of bits of data may be generated. The first set of bits and the second set of bits may be transmitted over a channel between a memory device and a host device in an interleaved pattern. The first code and the second code may also be transmitted over the channel. The first set of bits and the second set of bits may be deinterleaved by the receiving device. The first set of bits and the second set of bits may also be processed by the receiving device using the first code and the second code.

Abstract: The invention relates to bivalent bispecific monoclonal antibodies (bbmAb) or variants thereof, and methods of manufacturing such antibodies by co-expressing modified Fc-mutated derivatives of two different monoclonal antibodies in mammalian cell lines.

Abstract: A method for checking functionality of a motor vehicle braking system. The braking system has a main module, including: hydraulically actuatable wheel brakes, pairs being assigned to respective brake circuits; at least one electrically actuatable wheel valve per wheel brake sets wheel-specific brake pressures; a pressure provision device actively builds up pressure in the wheel brakes; a pressure-medium reservoir at atmospheric pressure, and an auxiliary module, which has for each of two wheel brakes: a pressure sensor for measuring pressure in a wheel brake line; an open when deenergized isolating valve in the wheel brake line; a pump. At least one variable is measured to assess functionality of the braking system. Using least one acceptance criterion, and checked whether the variable satisfies the acceptance criterion. Determining at least one variable representing the viscosity of the brake fluid, and the at least one acceptance criterion depends on a variable representing viscosity.

Abstract: A method for checking functionality of a motor vehicle braking system. The braking system has a main module, including: hydraulically actuatable wheel brakes, pairs being assigned to respective brake circuits; at least one electrically actuatable wheel valve per wheel brake sets wheel-specific brake pressures; a pressure provision device actively builds up pressure in the wheel brakes; a pressure-medium reservoir at atmospheric pressure, and an auxiliary module, which has for each of two wheel brakes: a pressure sensor for measuring pressure in a wheel brake line; an open when deenergized isolating valve in the wheel brake line; a pump. At least one variable is measured to assess functionality of the braking system. Using least one acceptance criterion, and checked whether the variable satisfies the acceptance criterion. Determining at least one variable representing the viscosity of the brake fluid, and the at least one acceptance criterion depends on a variable representing viscosity.

Abstract: Among other things, one or more techniques and/or systems are disclosed for identifying an area of interest comprising a desired object in imagery (e.g., so an image comprising the desired object may be altered in some manner). A determination can be made as to whether a capture event occurs within a proximity mask, where an object is not likely to be out of range if an image of the object is captured from within the proximity mask. For an image captured within the proximity mask, a determination can be made as to whether capture event imagery metadata for the image overlaps a footprint mask for the desired object. If so, the image may be regarded as comprising a discernible view of at least some of the desired object and is thus identified as an area of interest (e.g., that may be modified to accommodate privacy concerns, for example).

Abstract: Among other things, one or more techniques and/or systems are disclosed for identifying an area of interest comprising a desired object in imagery (e.g., so an image comprising the desired object may be altered in some manner). A determination can be made as to whether a capture event occurs within a proximity mask, where an object is not likely to be out of range if an image of the object is captured from within the proximity mask. For an image captured within the proximity mask, a determination can be made as to whether capture event imagery metadata for the image overlaps a footprint mask for the desired object. If so, the image may be regarded as comprising a discernible view of at least some of the desired object and is thus identified as an area of interest (e.g., that may be modified to accommodate privacy concerns, for example).

Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: A solid pharmaceutical composition for parenteral administration having an inner matrix containing at least one therapeutic agent, and a biodegradable, and water-impermeable coating covering part of the surface of said composition. The inner matrix disintegrates upon contact with animal tissue or tissue fluids. By providing a disintegratable and/or soluble inner matrix comprising the drug with a water-impermeable coating covering part of the surface of said composition, the rate of release of the drug can be controlled. The specific rate of release can be controlled by carefully designing the part of the surface which is not covered.

Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: Solid pharmaceutical compositions and methods of making and administering for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: Solid pharmaceutical compositions and methods of making and administering for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: A method, computer readable medium having computer executable instructions, and a computer readable medium having stored thereon a data structure for signing and validating Session Initiation Protocol (“SIP”) routing headers are disclosed. A SIP node may receive a SIP request including a message header. A signature based upon at least a portion of the message header and a SIP node header entry may be generated. The signature may then be inserted into the SIP node header entry.

Abstract: A sensor package is provided comprising an implantable sensor having an electrode area and an electric contact area, the package comprising a shielding packaging enclosing at least the electrode area of the sensor while exposing the electric contact area. The sensor package fascilitates handling of the implantable sensor and provides for the possibility of sterilising the electric contact area leaving the electrode area protected.

Abstract: The present invention relates to the field of pharmaceutical packaging. More specifically the present invention relates to a stopper made from a thermoplastic elastomer for the use in medical containers.

Abstract: Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.

Abstract: The present invention relates to a transfer device for transferring medicament from a medicament container to a syringe with a needle. The transfer device is arranged for transferring accurate dosages of insulin, growth hormone or other medicaments. The accuracy is ensured by the device comprising means for mounting a syringe to the device, the needle piercing a sealing of the device. Opposite the sealing a piston is arranged, said piston being non-releasable engaged with the piston driver during transfer of the medicament. Thereby the piston is not erroneously drawn from the piston driver, which would otherwise lead to incorrect dosing. Furthermore, the device comprises dosing means including the piston driver.

Abstract: A medicament container for storing a liquid medicament, such as insulin, comprises a wall with at least two opposite portions made of a polymer material having a light transmission at 400 nm of at least 25%, a glass transition temperature above 50° C., and a density of 0.95 g/cm3 or more. The polymer material comprises at least 70% by weight of a copolymer material composed of aliphatic cyclic or bicyclic hydrocarbons with 5 to 7 membered ring or rings and ethylene or propylene. The container is substantially inert to the medicament and, because it is either transparent or at least includes at least two opposed transparent portions, it is possible visually to inspect the contents of the container to make sure that the medicament has not crystalized or polymerized. The walls of the container provide a good barrier against m-cresol/phenol/benzyl alcohol preservatives and water.

Abstract: The present invention relates to a method of producing a pharmaceutical composition directly in a packaging material, a moulded packaging material comprising the pharmaceutical composition, a cassette comprising the packaging material, as well as a method of administering a dosage of the pharmaceutical composition for example directly from the packaging material.

Abstract: The present invention relates to a method and a system for producing an elongated drug formulation being suitable for being injected through the skin of a patient with-out the use of a needle or a cannula. The drug formulation is produced by compressing a drug granulate in cavity of a system comprising a roller and a surface, wherein the roller roles over the surface thereby comprising the granulate to the formulation.